EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan

Shigenori Ei iD, Shinichiro Takahashi iD, Toshihito Ogasawara iD, Taro Mashiko iD, Yoshihito Masuoka iD, Toshio Nakagohri iD

Gut and Liver · 2023

DOI: 10.5009/gnl220311 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gut and Liver, 2023. Verfasst von Shigenori Ei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansNeoadjuvant TherapyJapanAntineoplastic Combined Chemotherapy ProtocolsPancreatectomy

Stichwörter der Autor:innen

Adjuvant chemotherapyChemoradiotherapyClinical trialNeoadjuvant therapyPancreatic neoplasms

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.

ORCID-Profile: Shigenori Ei, Shinichiro Takahashi, Toshihito Ogasawara, Taro Mashiko, Yoshihito Masuoka, Toshio Nakagohri

Zitieren

APA

Ei, S., Takahashi, S., Ogasawara, T., Mashiko, T., Masuoka, Y., & Nakagohri, T. (2023). Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan. Gut and Liver. https://doi.org/10.5009/gnl220311

Vancouver

Ei S, Takahashi S, Ogasawara T, Mashiko T, Masuoka Y, Nakagohri T. Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan. Gut and Liver. 2023. doi:10.5009/gnl220311

BibTeX
@article{Ei2023,
  author = {Ei, Shigenori and Takahashi, Shinichiro and Ogasawara, Toshihito and Mashiko, Taro and Masuoka, Yoshihito and Nakagohri, Toshio},
  title = {Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan},
  journal = {Gut and Liver},
  year = {2023},
  doi = {10.5009/gnl220311}
}
Kostenlos starten →